SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-006883
Filing Date
2018-08-09
Accepted
2018-08-09 16:02:20
Documents
62
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kala-20180630x10q.htm 10-Q 1786978
2 EX-10.1 kala-20180630ex1013daa12.htm EX-10.1 95392
3 EX-10.2 kala-20180630ex102c25c8b.htm EX-10.2 75744
4 EX-10.3 kala-20180630ex1034ff662.htm EX-10.3 213911
5 EX-31.1 kala-20180630ex31103e7b5.htm EX-31.1 21326
6 EX-31.2 kala-20180630ex31286502e.htm EX-31.2 21324
7 EX-32.1 kala-20180630ex321ccf649.htm EX-32.1 9000
8 EX-32.2 kala-20180630ex3229e9533.htm EX-32.2 9411
9 GRAPHIC kala20180630ex1034ff662001.jpg GRAPHIC 8964
  Complete submission text file 0001558370-18-006883.txt   5993454

Data Files

Seq Description Document Type Size
10 EX-101.INS kala-20180630.xml EX-101.INS 1106798
11 EX-101.SCH kala-20180630.xsd EX-101.SCH 35081
12 EX-101.CAL kala-20180630_cal.xml EX-101.CAL 35604
13 EX-101.DEF kala-20180630_def.xml EX-101.DEF 114813
14 EX-101.LAB kala-20180630_lab.xml EX-101.LAB 338831
15 EX-101.PRE kala-20180630_pre.xml EX-101.PRE 243205
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38150 | Film No.: 181004948
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences